With its add-on software and higher performance coils, field-upgradeable MR scanners are the lifeblood of the imaging community. But systems with upgradeable fields are rare.
With its add-on software and higher performance coils, field-upgradeable MR scanners are the lifeblood of the imaging community. But systems with upgradeable fields are rare.
Philips Healthcare debuted the idea at RSNA 2006, touting its Achieva XR as the first and, so far, only 1.5T product that can be upgraded in the field to 3T. Thirty-nine of these multifield systems have been put in place since the device's unveiling. Philips argued that its Achieva XR can serve as a kind of insurance policy against obsolescence. Customers not ready to take the leap to 3T, Philips said, can use the Achieva XR at 1.5T indefinitely with the assurance that a higher field strength is just an upgrade away.
MetroHealth bought the scanner but not the argument. The 500-bed hospital ran its Achieva XR at 1.5T for only a month before ramping it to 3T. The idea was to teach staff the new Philips interface using a familiar field strength.
“We had some reservations about making this double jump, going to a new platform and going to 3T, so this offered us the opportunity to ease into it,” said Pedro Diaz, Ph.D., vice chair of imaging and informatics systems at MetroHealth.
Replacing its existing 1.5T scanner with the new Achieva XR spanned several weeks, according to Diaz. But the transition from 1.5T to 3T was done in a few days.
Scanning at 3T then began with the same user interface as at 1.5T, using the same patient setup, same coils, and, consequently, the same knowledge base. What staff had learned to do at 1.5T was applicable at 3T, Diaz said.
“Philips did a really good job of helping us find the replacement sequences for 3T,” he said.
Typically sites making this jump must compare images at the two field strengths taken on wholly different machines, possibly from different vendors. The Achieva XR provided MetroHealth the opportunity to directly compare 1.5T and 3T images taken under conditions that differed only in field strength. This baseline allowed staff to determine which patients are best imaged on the 3T Achieva and which on the 1.5T Philips scanner, also newly acquired.
The only cases now going automatically to 3T at MetroHealth are the obvious ones: spectroscopy, diffusion tensor imaging, and functional imaging. High-resolution brain angiography is done, when warranted, at 3T. Conversely, body MR scans that Diaz thought could be done only on the 1.5T machine because of artifacts typically associated with 3T, can, in fact, be done on the higher field scanner.
Both machines can handle routine scans. Achieva XR offers advantages in speed, due to the improved signal-to-noise ratio available at 3T, with the option of trading speed for better resolution. This kind of interchangeability was the goal behind MetroHealth's transition to two Philips high-field scanners.
“One of our fears was that everyone would want to have every patient done at 3T,” Diaz said. “The way we did it allowed us to make convincing arguments about what really absolutely needed to be done at 3T.”
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.